Merck Wins US Approval for a New Diabetes Drug
New York Times - Oct 18, 2006 By ALEX BERENSON. Federal drug regulators yesterday approved a new diabetes medicine from Merck that is expected to become a blockbuster treatment used by ...
|
|
|
|
|
FDA Faces Tough Choice On New Diabetes Drug
Forbes - Apr 3, 2009 Does a promising new class of diabetes drugs boost the risk of a rare thyroid tumor that may take decades to develop? That's the confusing and almost ...
|
|
FDA approves new diabetes drug Onglyza
msnbc.com - Aug 1, 2009 Levittown - Federal health regulators on Friday approved a potential blockbuster diabetes drug from Bristol-Myers Squibb Co. and partner Astrazeneca PLC. ...
|
|
|
|
New Diabetes Drug Gets FDA Panel's Backing
ABC News - Apr 1, 2009 An unapproved diabetes drug called saxagliptin has won the endorsement of a US Food and Drug Administration panel of experts, who said the drug doesn't ...
|
|
|